Feedback / Questions
CD30.CAR-T cell therapy - Tessa Therap
https://www.prnewswire.com/news-releases/tessa-therapeutics-announces-enrollment-of-12-patient-pilot-cohort-in-its-relapsed-or-refractory-hodgkin-lymphoma-phase-2-study-301281049.html
Apr 30, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next